Valuation: Pfizer Inc.

Market Cap 163B 143B 135B 123B 231B 15,662B 233B 1,621B 628B 8,001B 614B 600B 25,715B P/E 2026 *
18.1x
P/E 2027 * 14x
Enterprise Value 211B 185B 175B 159B 298B 20,213B 300B 2,092B 810B 10,326B 792B 775B 33,188B EV / Sales 2026 *
3.39x
EV / Sales 2027 * 3.42x
Free-Float
59.05%
Yield 2026 *
6%
Yield 2027 * 6.05%
1 day+0.05%
1 week+3.65%
Current month+0.74%
1 month+0.35%
3 months+21.12%
6 months+5.10%
Current year+15.14%
1 week 27.49
Extreme 27.49
28.85
1 month 27.24
Extreme 27.245
29.21
Current year 23.62
Extreme 23.62
29.21
1 year 23.62
Extreme 23.62
29.21
3 years 20.92
Extreme 20.915
34.11
5 years 20.92
Extreme 20.915
61.71
10 years 20.92
Extreme 20.915
61.71
Manager TitleAgeSince
Chief Executive Officer 64 2018-12-31
Director of Finance/CFO 55 2026-08-15
Compliance Officer 65 2013-11-30
Director TitleAgeSince
Director/Board Member 68 2007-08-31
Director/Board Member 62 2013-09-26
Chairman 64 2019-12-31
Date Insider Type Main position Quantity % Market Cap. Importance
9/15/26 Free

Chief Executive Officer

22 0.0000%
8/31/26 Free

Chief Executive Officer

21 0.0000%
8/17/26 Other

Chief Financial Officer

273,464 0.0048%
Change 5-day change 1-year change 3-year change Capi.($)
+0.92%+3.65%+21.48%-13.07% 163B
+0.13%+2.65%+65.61%+114.28% 1,055B
+0.20%+0.46%+52.60%+69.24% 654B
-0.29%+0.14%+20.96%+70.93% 467B
-0.85%+0.98%+41.29%+44.38% 348B
+0.71%+4.08%+22.24%+29.51% 275B
+1.23%+0.42%+14.57%+12.13% 258B
+2.11%+7.51%+52.89%+55.37% 224B
+0.83%+0.55%+35.99%+101.70% 187B
0.00%-10.14%-29.94%-60.30% 171B
Average +0.33%+1.03%+29.77%+42.42% 380.18B
Weighted average by Cap. +0.03%+1.42%+40.67%+64.35%

Financials

2026 *2027 *
Net sales 62.24B 54.61B 51.58B 47B 87.99B 5,965B 88.62B 617B 239B 3,047B 234B 229B 9,794B 59.77B 52.45B 49.53B 45.14B 84.5B 5,728B 85.1B 593B 230B 2,926B 224B 220B 9,405B
Net income 8.9B 7.81B 7.38B 6.72B 12.58B 853B 12.67B 88.27B 34.19B 436B 33.42B 32.69B 1,401B 11.08B 9.72B 9.18B 8.37B 15.67B 1,062B 15.78B 110B 42.56B 543B 41.6B 40.7B 1,744B
Net Debt 47.48B 41.67B 39.35B 35.86B 67.13B 4,551B 67.61B 471B 182B 2,325B 178B 174B 7,472B 40.98B 35.96B 33.96B 30.95B 57.94B 3,928B 58.35B 406B 157B 2,007B 154B 151B 6,449B
Logo Pfizer Inc.
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (42.9%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (28%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (26.9%); - other (2.2%). The United States accounts for 59.2% of net sales.
Employees
75,000
Date Price Change Volume
26-09-25 US$28.67 +0.92% 27,763,664
26-09-24 US$28.41 +0.82% 34,774,742
26-09-23 US$28.18 +0.90% 33,812,863
26-09-22 US$27.93 +0.68% 26,669,292
26-09-21 US$27.74 +0.29% 28,776,627
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
28.67USD
Average target price
28.88USD
Spread / Average Target
+0.72%

Quarterly revenue - Rate of surprise